Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …
Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

